EU: Checklist for Brexit Preparation
Recommendation

10/11 February 2026
Heidelberg, Germany
Medicinal Products/Drugs meet Medical Devices
The end of the transition period is approaching and no agreement is in sight. Having first published a Communication to prepare for the end of the transition period, the European Commission has now published a respective 'Brexit Readiness Checklist' for companies doing business with the UK. This checklist is designed to help EU companies doing business in the UK (United Kingdom; UK) and/or UK companies doing business in the EU to check exactly how well prepared they are for 1 January 2021.
Some of the key points are:
- Companies should familiarise themselves with the obligations of an exporter or importer in relation to trade with third countries.
- Accordingly, companies should inform themselves about relevant EU customs formalities.
- In future, companies should provide proof of the originating status of goods (this also applies to the corresponding supplier declarations).
- Certificates and approvals from a UK authority or body must be transferred to an EU authority/body. New certificates or approvals may have to be applied for. Products certified only by UK-based authorities/bodies may no longer be placed on the EU market.
- As EU REACH regulation (Registration, Evaluation, Authorisation and Restriction of Chemicals) will no longer apply in the UK, companies must ensure that substances are registered with a manufacturer or importer in the EU.
Related GMP News
04.02.2026When Training Falls Short: FDA Findings on GMP Training Deficiencies in 2025
27.01.2026New Ph. Eur. Publication Schedule
21.01.2026EU Pharma Package: EMA with single Point of Information
14.01.2026European QP Association Developments September through December 2025
14.01.2026Could a change of ownership be relevant to GMP?
07.01.2026Is QP Certification required when Products do not enter EU Territory?


